A protocol deviation or violation is any departure from the study procedures or treatment plans as specified in the IRB-approved protocol. Learn more about protocol deviations at the University of ...

These collected resources can help when you're developing IRB protocols and related materials. If you have further questions after reviewing these materials, please contact our office. We also ...

XyloCor Therapeutics Announces Presentation of Preliminary Clinical Data from Phase 1 Portion of the EXACT Phase 1/2 Study of XC001 Novel Gene Therapy for Refractory Angina at AATS and ASGCT ...

Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Study Overview: Eli Lilly and Company is spearheading the ...

Intensity Therapeutics, Inc.'s Phase 3 INVINCIBLE-3 Sarcoma Study Selected for Presentation at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting ...

Ankyra Therapeutics Announces Trial in Progress Poster Presentation at 2024 ASCO Meeting and Approval of ANK-101 Phase 1 Protocol Amendment ...

The Clinical Research Unit (CRU) is committed to providing investigators and their teams a research environment and broad range of services guided by good clinical practice. This contributes to the ...

ENACT-HF was not powered to look at these endpoints and weight measurements were not standardized in the study protocol. Congestion score, too, would typically take a few more days for a difference ...

Cardiovascular researchers at UC Davis Health have developed a novel technique that allows scientists to study how the brain ...

A presentation slated to be shared at this week’s meeting of vaccine advisers to the US Centers for Disease Control and Prevention claimed that a study in animals suggested that use of the ...